• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Non-drug interventions highly efficacious at reducing depressive symptoms in people with dementia

byJessie WillisandTeddy Guo
April 30, 2021
in Chronic Disease, Neurology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Systematic review found that social prescribing was associated with a reduction in depressive symptoms in patients with dementia without a diagnosis of major depressive disorder.

2. Non-drug interventions either alone or in combination with drug interventions may be the most efficacious intervention for these patients.

Evidence Rating Level: 1 (Excellent)

Study Rundown: 32% of people diagnosed with dementia experience depressive symptoms without meeting the full criteria for major depressive disorder. In the elderly population, antidepressants may do more harm than good, due to increased risk of falls and other side effects. It is therefore important that social prescribing, or non-drug interventions, are evaluated as potential therapies. In this systematic review and meta-analysis of 256 articles, ten non-drug therapies were found to be more effective at treating depressive symptoms than usual care. These social therapies included cognitive stimulation, exercise, social interaction, massage therapy and animal therapy. Massage and touch therapy, as well as cognitive stimulation combined with either exercise and social interaction or cholinesterase inhibitors were found to be more effective than some drug therapies. Many social therapies were found to have a high likelihood of lowering depressive symptoms, reported on the Cornell Score. Furthermore, drug interventions alone were not found to be significantly more effective than non-drug interventions or treatment as usual in this population. More research still needs to be done for non-Alzheimer’s dementia, intervention risks, as well as feasibility. While shown to have a high likelihood of successfully lowering depressive symptoms, these therapies may pose challenges to many members of an aging population. Many elderly people have difficulties with ambulation, hearing, and/or vision, which may impact their ability to utilize social interventions. Nonetheless, this is a large-scale systematic review with conclusions that are important for clinical consideration by physicians, caregivers, and patients.

Click to read the study in the BMJ

Click to read an accompanying editorial in the BMJ

Relevant Reading: Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease

RELATED REPORTS

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

Islamic-based interventions may improve both depression and anxiety

Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

In-Depth [systematic review and meta-analysis]: 3542 full text articles were screened for a final total of 256 articles included in the systematic review. Inclusion criteria included randomized control trials of drug and non-drug therapies with the primary outcome of depressive symptoms in patients with dementia. The most common outcome measure was the Cornell scale for depression in dementia. 213/256 studies, which totaled 25 177 people with dementia, were included in the meta-analysis. Ten therapies were found to be more effective than treatment as usual for reducing depressive symptoms in people with dementia without a diagnosis of major depressive disorder: cognitive stimulation, cognitive stimulation combined with a cholinesterase inhibitor, exercise combined with social interaction and cognitive stimulation, massage and touch therapy, multidisciplinary care, occupational therapy, reminiscence therapy, animal therapy, exercise, and psychotherapy combined with reminiscence therapy and environmental medication. Treatment as usual was defined as adequate access to clinical care, such as nurse or doctor visits. No statistical difference was seen between the efficacy of non-drug therapies and drug therapies, except for cognitive stimulation combined with exercise and social interaction, cognitive stimulation combined with cholinesterase inhibitor, and massage and touch therapy, which were found to be more effective than some drugs.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: alzheimerAlzheimer’s diseaseanimal therapycholinesterase inhibitorcognitive stimulationdementiadepressiondepressive symptomsexercisemassage and touch therapyoccupational therapypsychotherapyreminiscence therapysocial interactionsocial prescribing
Previous Post

#VisualAbstract GHSG HD14: Intensified chemotherapy regimen (BEACOPP+ABVD) improved progression-free survival without improving overall survival over long-term follow-up

Next Post

2 Minute Medicine Rewind May 3, 2021

RelatedReports

#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial
StudyGraphics

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 29, 2022
Children’s hospital visits for suicide ideation and attempts are increasing
Psychiatry

Islamic-based interventions may improve both depression and anxiety

June 22, 2022
Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress
Chronic Disease

Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 17, 2022
Wellness

Wellness Check: Spirituality

June 21, 2022
Next Post

2 Minute Medicine Rewind May 3, 2021

Delays in surgical intervention do not increase odds of appendiceal perforation

Bariatric surgery vs community weight management for idiopathic intracranial hypertension

Obstetric scoring systems overestimate cases of severe sepsis

Sepsis performance measure implementation not associated with clinical outcomes improvement

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic
  • Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]
  • Cognitive behavioral therapy efficacious for treatment of comorbid posttraumatic headache and posttraumatic stress disorder symptoms among US veterans
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.